Product Program year 2024 Source: CMS Open Payments

Stravix

MedicalSupply Extremities & Limb Restoration

Open in the dashboard

General payments

$2,634,166

24,766 payments

Research payments

$217,242

10 payments

Through program year 2024, $2,634,166 in general payments and $217,242 in research payments were reported against Stravix (Extremities & Limb Restoration).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 General $800,434 5,151
2024 Research $2,600 1
2023 General $610,153 5,752
2023 Research $76,473 2
2022 General $710,372 6,612
2022 Research $96,101 5
2021 General $513,207 7,251
2021 Research $42,069 2

Breakdown

Who paid General payments · program years 2021–2024
  1. Smith+Nephew, Inc. $2,634,166 24,766 payments
Top recipients General payments · program year 2024
  1. Thomas Jefferson Univ. Hospital Teaching hospital · PA $110,793 14% · 2 payments
  2. Vineet Mehan Plastic Surgery · Falls Church, VA $50,540 6% · 49 payments
  3. Charles Parks Podiatrist, Foot & Ankle Surgery · San Francisco, CA $43,110 5% · 39 payments
  4. Harry Schneider Podiatrist, Foot & Ankle Surgery · Cambridge, MA $35,079 4% · 33 payments
  5. Brett Chatman Surgery · Philadelphia, PA $31,893 4% · 29 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Podiatrist, Foot & Ankle Surgery Podiatrist $171,813 32% · 740 practitioners
  2. Plastic Surgery $82,383 15% · 78 practitioners
  3. Surgery $76,194 14% · 375 practitioners
  4. Podiatrist $64,867 12% · 358 practitioners
  5. Orthopaedic Surgery $34,254 6% · 153 practitioners

The top 5 of 89 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Pennsylvania $195,404 24% · 292 recipients
  2. California $73,207 9% · 246 recipients
  3. Virginia $65,155 8% · 46 recipients
  4. Connecticut $46,770 6% · 58 recipients
  5. Texas $46,736 6% · 243 recipients

The top 5 of 53 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

24,766 general · 10 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record